SECOND AMENDMENT TO DECEMBER 22, 2017 LICENSE AGREEMENTLicense Agreement • May 31st, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances
THIS Second Amendment to the December 22, 2017 License Agreement ("Second Amendment"), effective as of the date of execution by both parties (the "Effective Date"), is made by and between MDNA Life Sciences Inc. ("MDNA") and ("__"). __ and MDNA may be referred to herein each as a "Party" or collectively as "Parties."
LICENSE AGREEMENTLicense Agreement • May 31st, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances • Delaware
This License Agreement ("Agreement") is entered into by and between MDNA Life Sciences Inc., a Delaware corporation ("MDNA"), and _____, a Delaware corporation ("__"), as of the 22nd day of December, 2017 (the "Effective Date").
FIRST AMENDMENT TO DECEMBER 22, 2017 LICENSE AGREEMENTLicense Agreement • May 31st, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances
THIS First Amendment to the December 22, 2017 License Agreement ("First Amendment"), effective as of the date last written below (the "Effective Date"), is made by and between MDNA Life Sciences Inc. ("MDNA") and _____ ("_____"). MDNA and _____ may be referred to herein each as a "Party" or collectively as "Parties."
